Cargando…
Acquired pure red cell aplasia: updated review of treatment
Pure red cell aplasia (PRCA) is a syndrome characterized by a severe normocytic anaemia, reticulocytopenia, and absence of erythroblasts from an otherwise normal bone marrow. Primary PRCA, or secondary PRCA which has not responded to treatment of the underlying disease, is treated as an immunologica...
Autores principales: | Sawada, Kenichi, Fujishima, Naohito, Hirokawa, Makoto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592349/ https://www.ncbi.nlm.nih.gov/pubmed/18510682 http://dx.doi.org/10.1111/j.1365-2141.2008.07216.x |
Ejemplares similares
-
Clonal hematopoiesis in adult pure red cell aplasia
por: Fujishima, Naohito, et al.
Publicado: (2021) -
Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021) -
Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan
por: Nakazawa, Hideyuki, et al.
Publicado: (2022) -
Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia
por: Gangat, Naseema, et al.
Publicado: (2022) -
Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis
por: Lobbes, Hervé, et al.
Publicado: (2023)